Monday, March 09, 2020 11:13:26 AM
Recent AIM News
- AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/16/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:31:34 PM
- AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast • GlobeNewswire Inc. • 05/09/2024 12:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 12:30:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 12:30:31 PM
- AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® • GlobeNewswire Inc. • 05/06/2024 12:30:00 PM
- AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer • GlobeNewswire Inc. • 04/29/2024 12:55:00 PM
- AIM ImmunoTech Announces Release of the Next CEO Corner Segment • GlobeNewswire Inc. • 04/25/2024 12:45:00 PM
- AIM ImmunoTech Announces Release of the Next CEO Corner Segment • GlobeNewswire Inc. • 04/18/2024 12:45:00 PM
- AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs • GlobeNewswire Inc. • 04/15/2024 12:55:00 PM
- AIM ImmunoTech Announces Release of the Next CEO Corner Segment • GlobeNewswire Inc. • 04/11/2024 03:00:00 PM
- AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer • GlobeNewswire Inc. • 04/10/2024 12:21:00 PM
- AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
- AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference • GlobeNewswire Inc. • 03/28/2024 12:05:00 PM
- AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast • GlobeNewswire Inc. • 03/26/2024 01:05:00 PM
- AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research • GlobeNewswire Inc. • 03/25/2024 01:05:00 PM
- AIM ImmunoTech Announces Release of the Next CEO Corner Segment • GlobeNewswire Inc. • 03/22/2024 12:55:00 PM
- AIM ImmunoTech Announces Release of the Next CEO Corner Segment • GlobeNewswire Inc. • 03/20/2024 01:25:00 PM
- AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity • GlobeNewswire Inc. • 03/15/2024 12:45:00 PM
- AIM ImmunoTech Announces Launch of CEO Corner Platform • GlobeNewswire Inc. • 03/07/2024 01:45:00 PM
- AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 01:45:00 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 02/21/2024 03:37:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:31:03 PM
- AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer • GlobeNewswire Inc. • 02/14/2024 01:55:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM